Conclusion Ipamorelin represents a highly selective growth hormone secretagogue with receptor specificity that enables effective GH stimulation without substantial activation of other endocrine pathways
R: Synergistic combinations studied: BPC-157/TB-500: Enhanced Musculoskeletal Regeneration Metformin: Improve insulin sensitivity (resistance prevention) Testosterone Additive anabolic effects (aging studies) Tirzepatide/Semaglutide: Complementary for body recomposition Avoid: Combination with exogenous insulin without strict monitoring
This is the most frequently reported effect and is inherent to GHRP-6's mechanism Mild water retention and peripheral edema, particularly during the first 2 to 4 weeks Transient flushing, warmth, or dizziness immediately post-injection Injection site reactions (redness, minor swelling) Less Common: Tingling or numbness in the extremities (hands and feet), related to GH-mediated fluid shifts Head rush or lightheadedness shortly after administration Drowsiness, particularly with evening doses Dose-Dependent (above saturation dose): Elevated cortisol via ACTH stimulation
AOD-9604: The Anti-Obesity Drug for Targeted Muscle Definition AOD-9604 is a modified fragment of the growth hormone molecule
This is standard medical practice same way doctors prescribe medications for uses beyond their original approval all the time